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G97-1324-A

Beef Cattle Implant Update
This NebGuide discusses the mechanism of action and use strategies for growth promoting
implants, including expected responses and cost analysis.
Dee Griffin, DVM, MS, Extension Veterinarian
Terry Mader, PhD, Extension Beef Specialist
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Introduction
Growth promoting implants have been used extensively in beef production for over 30 years. Significant
changes in implants and implanting strategies have occurred. Prior to 1987, available implants were
estrogenic agents which metabolically enhanced nutrient use to enhance growth. These products
improved feed efficiency 5-10 percent and daily gains from 5-15 percent. In 1987, the androgenic (tissue
building) agent, trenbolone acetate, was approved for use in growth promoting implants. This compound
had an additive effect with existing estrogenic implants. The androgenic implant enhanced muscle growth
and added an additional 2-3 percent to the feed efficiency and 3-5 percent to the daily gains. The return
on implant investment varies, but only in rare situations do implants return less than $5 per $1 spent.
Implants are available for all cattle except calves less than 45 days old and most breeding cattle. Proper
scheduling and use of implants should return in excess of $10 per $1 spent.
Today, implants have become almost designer products with varied doses and combinations of estrogenic
and/or androgenic agents. While implants tend to be most effective in feed yards, implanting strategies
have been effectively applied to other beef production situations. The growth promoting implants
approved for use in the United States are extremely safe. Safe not only for the cattle, but for producers
who use the products and for the consumers who consume the beef produced from implanted cattle.

There is no withdrawal time for any of the approved implants available in the United States.

Mechanism of Action
Cattle must have adequate nutrition before implants can positively influence feed efficiency and gain.
The greatest response to implants tends to be observed in older cattle, near peak periods of lean tissue
deposition. Typically these would be yearling cattle consuming high levels of high energy feed.
Estrogenic implants increase the circulating levels of somatotropin (ST) and insulin-like growth factor-1
(IGF-1). Both of these substances are produced by the animal and have a marked effect on how nutrients
are used by the animal to produce muscle, bone, and fat. The approved androgenic agent, trenbolone
acetate (TBA), does not seem to stimulate the production of ST, but does significantly increase the
circulating levels of IGF-1 and decreases the normal loss of muscle tissue in sedentary animals. The
implant response is associated with nutrients available and the level of implant growth promotant
circulating in the animal.
When growth promoting implants are first placed in the animal, there is a rapid release of hormone from
the implant. The level of growth promotant being released from the implant will begin to fall after a few
days but will remain above an effective growth stimulating level, "threshold," for a varying length of time
depending on the pharmaceutical design of the implant and the quality of technique used when
administering the implant placement. Reimplanting, the administration of an additional implant, is
usually scheduled to coincide with the declining level of circulating implant growth promotant, but
always above threshold. The optimum reimplant time is referred to as the reimplant window. For
maximum benefit, it is important to maintain the level of implant growth promotant above threshold
throughout the ownership of the stocker or feeder animal. The length of time an implant releases growth
promotant above threshold, "payout," varies from approximately 75 days for Ralgro® to the
manufacturer's estimated 200 days for Compudose®. The improvements in rates of gain appear to follow
the declining level of growth promotant released from an implant. Therefore, the highest rates of gain can
be expected during the first part of the payout period.
Because implant growth promotants interact with the production of hormones produced by the animal,
they have not been recommended or approved for use in breeding cattle or calves less than 45 days of
age.

Implant Performance
The estrogenic implants approved for use in suckling calves will improve weaning weights 3-5 percent.
Similar performance improvements can be seen in pastured stocker cattle when the base gain is above 1.5
pounds per day.
Previously implanted cattle are of concern to cattle buyers who take advantage of compensatory gain
potential of cattle. Producers should receive a premium equivalent to the loss of production to consider
not implanting suckling calves or stocker cattle.
In feeder cattle, estrogenic growth promoting implants improve feed efficiency and gain 5-15 percent.
Implants which include TBA can provide an additional 3-5 percent improvement in feed efficiency and
daily gain. A properly designed reimplant program can sustain implant associated improved performance
beyond the payout that would be expected for a single implant.
For estrogenic implants used in yearling cattle fed typical Nebraska feedlot rations, at least a $5 return

above the cost of the implant can be expected for each $1 price of a bushel of corn. Adding TBA to an
estrogen implant system will return an additional $2 above the cost of the implant for each $1 price of a
bushel of corn. For example, if corn costs $3 per bushel, an estrogenic implant would return
approximately $15. Implants containing TBA would return approximately $21 when used in cattle fed $3
corn.
While cull cows are not typical feeders, limited data suggest they respond to implants at or above the
level of younger feeder animals, especially to TBA. Most cull cows are not fed long enough to consider a
reimplanting program.

Implant Use
Regulations governing the use of implants are set by the U.S. Food and Drug Administration (FDA).
Always read and follow the manufacturer's directions before implanting any cattle.
The only approved location for implant administration is the middle third of the back side of the ear. All
implants must be located within this area (Figure 1). If part of the ear has been lost because of frost bite
or injury, the implant should be placed in the last third of the ear. This should place the implant outside
the cartilage ring at the base of the ear. Implants should never be placed in locations other than the ear.
Implanting technique defects are a serious
economic concern because of suspected
associated performance loss. Defects of
concern include abscesses, expelled
implants, cartilage embedment, crushed
pellets, missing pellets, and bunched pellets.
Identification of these defects can be hard to
determine. Generally abscesses will be
enlarged and will feel doughy. If the abscess
ruptures, the implant will be expelled leaving
a very small ring of scar tissue. Some
Figure 1.
implant sites will accumulate fluid that is not
associated with an infection and do not seem to be associated with implanting technique. Cartilage
embedment should be suspected when the implant feels firmly attached to the deeper tissues of the ear or
when you cannot feel the roughened edge of the implant. While no published data are available to
validate an associated economic loss from these defects, unpublished data from work conducted at the
University of Nebraska Great Plains Veterinary Educational Center during the summer of 1996 suggest
abnormal implants are associated with 0.17 pound reduction in carcass gain in cattle fed 150 days¹.
Common sense suggests better performance could be expected in cattle free of implant defects.
The loss of implants before payout can be avoided if the implants are properly located in a dry ear with a
clean implanting needle. If the ear is wet, it should be dried before implanting. If the ear is covered with
wet manure or mud, the filth should be scraped or washed off and the ear dried. The needle should be
cleaned between each animal with a diluted disinfectant. If the needle slips over the surface of the ear, it
should be cleaned before continuing. The tissue irritation caused by an undiluted disinfectant can cause
the expulsion of an implant or the formation of scar tissue which could interfere with the effective release
of growth promotant from the implant. Care should be taken when selecting an implant needle cleaning
solution. One ounce of chlorhexidine, the blue disinfectant, per gallon of water is an effective implant
needle cleaning solution while alcohol is not. Some feedyards coat the cleaned implanting needle with an
approved, non-irritating antibiotic between animals as an additional safeguard to help prevent implant site
infections. Visit with your veterinarian about the selection, dilution, and use of a disinfectant.

Developing a light touch and slightly rotating the needle when implanting is the best defense against
cartilage embedment. A properly placed implant will be slightly movable.
Missing or bunching of implant pellets can be avoided by carefully restraining the animal and slowly
withdrawing the implant needle as the implant is being administered. Implant guns and needles are
available from the companies that manufacture growth promoting implants. All implants can be
effectively administered with the implant gun designed for the associated implant. It is important to
visually inspect and physically palpate the implant site after the implant is administered to ensure the
implant is properly placed and all the pellets in the pelleted implants are properly aligned. As part of the
inspection, the implant needle opening should be closed by pressing down on the hole. Most of the
problems with implant guns can be avoided by closely following the manufacturer's directions.
Implant restraint bars or plates have become common on processing chutes. They effectively hold the
animal's head still, making it much easier to properly place the implant. However, implant restraint bars
and plates will cause the loss of four to six inches of exposed neck available for injection making it more
difficult to properly give neck injections. Because injection site damage in the rump and round is a
serious concern of the beef industry, we recommend giving all antibiotic and vaccine injections in the
neck and, therefore, do not recommend the use of implant restraint bars or plates. If cattle are caught
properly, just behind the ears, in an unmodified head gate, implanting restraint bars or plates are not
needed to properly place implants.
Routine inspection of implant and vaccine sites should be done every time animals are handled through a
chute and at periodic quality audits performed at packing houses. A practical and consistent inspection
can be accomplished on each animal that enters the hospital.

Table I. Available Implants
Name
Ralgro®

Estrogen Progesterone
(mg/implant) (mg/implant)

Androgenic
(mg/implant)

36 mg
zeranola

Target
Cattle

Reimplant
Window

Estimated
Payout

Stocker/feeders over 45 days 45 - 90 days
of age

70 - 100
days

Synovex-C®

10 mg
E2 benzoateb

100 mg
progesterone

Calves between 45 days age 45 - 90 days
and weaning

100 - 140
days

Calfoid®

10 mg
E2 benzoateb

100 mg
progesterone

Calves between 45 days age 45 - 90 days
and weaning

100 - 140
days

Pastured stocker and feeder
steers

120 days

100 - 140
days

72 mg
zeranola

Weaned stocker and feeder
cattle

70 - 100
days

100 - 120
days

Compudose®

24 mg
E2 - 17β c

Calves, stockers, and feeder
cattle

140 - 170
days

170 - 200
days

Synovex-S®

20 mg
E2 benzoateb

200 mg
progesterone

Weaned stocker and feeder
steers

70 - 100
days

100 - 140
days

Implus-S®

20 mg
E2 benzoateb

200 mg
progesterone

Weaned stocker and feeder
steers

70 - 100
days

100 - 140
days

Revalor-G®

Magnum®

8 mg
E2 - 17β c

40 mg
trenbolone
acetated

Revalor-S®

24 mg
E2 - 17β c

Finaplix-S®

120 mg
trenbolone
acetated

Weaned stocker and feeder
steers

90 - 100
days

100 - 140
days

140 mg
trenbolone
acetated

Weaned stocker and feeder
steers

70 - 100
days

60 - 100
days

Synovex-H®

20 mg
E2 benzoateb

200 mg
testosterone

Weaned stocker and feeder
heifers

70 - 100
days

100 - 140
days

Implus-H®

20 mg
E2 benzoateb

200 mg
testosterone

Weaned stocker and feeder
heifers

70 - 100
days

100 - 140
days

Revalor-H®

14 mg
E2 - 17β c

140 mg
trenbolone
acetated

Weaned stocker and feeder
heifers

90 - 100
days

100 - 140
days

200
mg trenbolone
acetated

Weaned stocker and feeder
heifers

70 - 100
days

60 - 100
days

200 mg
trenbolone
acetated

Weaned stocker and feeder
steers

90 - 100
days

100 - 140
days

Finaplix-H®

Synovex
Plus®
azeranol

28 mg
E2 benzoateb

contains 30-33% the estrogenic activity of Estradiol-17β (E2 - 17β).

bE

2 benzoate is
cEstradiol-17β.

approximately 72% the estrogenic activity of Estradiol-17β (E2 - 17β).

d Trenbolone

acetate is often abbreviated as TBA.
Compudose is a trademark of Elanco.
Ralgro and Magnum are trademarks of Mallinckrodt Veterinary, Inc.
Synovex-C, -S, -H, and Plus are trademarks of Fort Dodge Animal Health.
Finaplix-S, -H, Revalor-S, -H, -G are trademarks of Hoechst-Roussel Agri-Vet Co.
Calfoid, Implus-S and -H are trademarks of the Up-John Co.

Other Considerations
Implanting heifers intended to enter the breeding herd is controversial. The mixed results from research
trials suggest detailed management considerations must be adhered to before considering an implant
program for replacement heifers. Highlights of these considerations include selecting an implant
approved for use in replacement heifers, providing adequate nutrition for growth, and leaving adequate
time between implanting and breeding.
Implanting replacement breeding bull calves is not approved or recommended.

Implanting Strategies
It is important to implant cattle as soon as practical. In suckling calves, the traditional branding time in
Nebraska provides an excellent opportunity to implant and vaccinate most of the calves in the herd. Prior
to bull turn out, the preferred procedures include vaccination with subcutaneously administered modified
live four way viral and clostridial vaccines, and implanting calves older than 45 days old with a product
designed for suckling calves. It is important not to implant replacement heifers and never implant bull
calves intended to be kept for breeding purposes unless strict adherence to manufacturer's directions are
followed.

Calves at weaning not intended for breeding should be implanted again with a more aggressive implant.
The feeder implant can be either an estrogenic implant or a combination estrogenic-trenbolone implant. It
appears to be important to finish the feeding period with the most potent implant selected in the
implanting program (Table II). Therefore, if a combination estrogenic-trenbolone implant is selected as
the first implant, it should be used again in subsequent implantings. If an estrogenic implant without
trenbolone is selected as the first implant, a similar product can be selected for subsequent implanting or
an estrogenic-trenbolone implant may be selected.
Name
Ralgro
Synovex-C
Calfoid
Duralease
Magnum
Synovex-S/H
Implus-S/H
Finaplix-S/H
Revalor-IS/IH
Synovex Choice
Finaplix-S/H
Revalor-S/H
Synovex Plus

Table 2. Implant Relative Potency and Payout Rank
Hormonal Activity Relative Potency Re-Implant Window c Optimum Payout Period (days)
45 – 90 days
Low
60 – 90 days
Estrogen ab
45 – 90 days
Low
60 – 90 days
Estrogen ab
ab
45
–
90
days
Low
60 – 90 days
Estrogen
70 –100 days
Moderate
80 – 120 days
Estrogen ab
70 –100 days
Moderate
80 – 120 days
Estrogen ab
ab
70 –100 days
Moderate
80 – 120 days
Estrogen
ab
70
–100
days
Moderate
80 – 120 days
Estrogen
60 –80 days
Moderate
60 – 80 days
Androgen ab
ab
70
–100
days
Androgen Estrogen
Moderate
90 –120 days
ab
Androgen ab Estrogen
ab

Androgen ab Estrogen
ab

Androgen ab Estrogen
ab

Androgen ab Estrogen
ab

Moderate
High
High
High

70 –100 days
90 –100 days
90 –100 days
90 –100 days

120 –140 days
90 – 110 days
90 – 120 days
90 – 120 days

a See notations for Table 1. b Androgen and Estrogen is denoted as A and E in the Figure 2. c Re-implanting prior to the shortest days listed in the reimplant window can lead to severe side effects such as prolapses and decrease in gain and / or efficiency performance.

Reimplant schedules should be developed to reflect the targeted finish date, the historic grade price spreads, the genetic
potential of the cattle, and the feeding program available. From the projected finish date, reimplanting should be scheduled by
back calculating the payout days of the last implant intended for use.
For example, if 550-pound medium to large frame weaned steer calves enter the feedyard the first of October, an estrogenic
product such as Magnum®, Synovex-S®, or Implus-S® can be selected as the initial implant. If the cattle are projected to gain
3 pounds per day and be marketed at 1,100 pounds, the estimated sale date would be the first two weeks of April. Back
calculating the 120-day payout of a combination estrogenic-trenbolone implant from the middle of April, reimplanting would
be scheduled for the middle to the end of December.
Maintaining implanting schedules can be very difficult, but tremendous performance advantages can be achieved if properly
managed. If you have any questions, seek the advice of a qualified feedlot nutritionist or veterinarian.
Figure 2 Implant Program Relative To Days From The Packer To Achieve Desired Finish End Point (DFEP)
Note: The diagram is interpreted bottom to top. Each column represents an individual example of the length of days the
animal will be finished – Days On Feed (DOF). All protocols should be designed so that the implant has been use up by
the time the animal is scheduled to go to the packer. NEVER, give an implant before any previous implant has met the reimplant window.
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Ration Considerations
Although no special ration considerations are needed for maximal implant performance, it is important to feed a balanced high
quality ration. All approved feed additives used in an approved manner are appropriate to consider in a feeding program for
implanted cattle. Performance improvements associated with approved feed medications are additive to the expected
performance improvements from implants.

Side Effects
Heavy carcass weight can be a problem when feeding large frame exotic long yearlings. Typically, implanted cattle will be
heavier when finished and with the same quality grade as non-implanted cattle. Weight discounts in the magnitude of 15
percent of the carcass value can be applied to carcasses that weighed over 950 pounds or live cattle that weighed over 1,500
pounds. This problem can be minimized if cattle start on feed at a lighter weight, using only estrogenic implants or targeting
the finishing to achieve the select grade instead of choice grade.
Poor yield grades have been reported in heifers implanted with combination estrogenic-trenbolone implants and concurrently
fed the feed additive melengestrerol acetate (MGA). These observations were made in studies designed to evaluate the benefits
of a combination implant. It is likely the heifers were overfed. It is important in any feedlot management program to evaluate
cattle near their target finishing date, and market the cattle as soon as the cattle reach the most economical degree of finish.
Poor quality grades can be a problem if implanting schedules are not properly designed to match the age, weight, genetics, and
nutritional management of the cattle. It is always important to consider the historic quality grade price spreads at the targeted
finishing date.
An increase in the buller rate has been reported with the use of some implants. Crushing implants has also been blamed on the
increased buller rate in some groups of implanted animals. With the modern implanting tools available today, this problem
seems unlikely. The effects of climatic changes, ambient temperature, animal handling, commingling, feed stuffs containing
fungal or plant estrogens, and implant technique seem more likely to play a role in these observations.
Vaginal and rectal prolapses have been reported as an implant side effect. If hormones are involved in these occurrences, it is
possible additional estrogenic compounds from the feed are also involved. These compounds could come from feed molds or
from some classes of feeds such as legumes containing phytoestrogens. Other suspected causes include improper implanting
technique or improper implant scheduling.

High tailheads, sunken loins, udder development, and heavy hide weights have also been reported. These problems are
generally rare or have minor economic significance when compared to the performance benefit realized from the use of
implants.

Conclusions
Using growth promoting implants is one of the most cost effective methods of enhancing cattle gain and efficiency of gain.
Implants enhance protein deposition while diminishing fat accretion. Properly designed implant programs should take into
account animal age, sex, weight, breed and market objectives. Meat and animal products from cattle implanted with growth
promotants are as safe and acceptable as comparable products derived from nonimplanted cattle.
¹This data was presented at the 1996 Academy of Veterinary Consultants Meeting.
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